Live Breaking News & Updates on Laboratorios Grin|Page 1
Stay updated with breaking news from Laboratorios grin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press Release Nicox Raises €10 Million in Private PlacementNet proceeds from the private placement to extend the cash runway to mid-May 2024Warrants to be issued in the private placement could provide ....
Press Release Nicox Raises €10 Million in Private PlacementNet proceeds from the private placement to extend the cash runway to mid-May 2024Warrants to be issued in the private placement could provide ....
Press ReleaseNicox's Partner Ocumension Obtains Positive Phase 3 Clinical Trial Results for ZERVIATE in China ZERVIATE (cetirizine ophthalmic solution), 0.24% was non-inferior to comparator ....
Press ReleaseNicox European Patent Seals ZERVIATE Major Market Coverage to 2030 Patent coverage for ZERVIATE (cetirizine ophthalmic solution), 0.24% in Europe until 2030 January 5, 2022 - release ....
Nicox Provides Second Quarter 2021 Business and Financial Highlights and Strategic Update Lead value drivers are 100% ownership of NCX 470 and NCX 4251 in the U.S . 21 C sufficient for the Company to meet its current requirements for the next twelve months July 16, 2021 - release at 7:30 am CET Sophia Antipolis, France Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, provided business and financial highlights for Q2 2021 for Nicox SA and its subsidiaries (the Nicox Group ) as well as an update on its strategy and key expected value-inflection milestones today.
timely NCX 4251 etain the full revenue poten tial from in the U.S. ....